Mumbai (Maharashtra) [India], May 19: HVAX Technologies Limited (NSE -HVAX), a turnkey pharmaceutical project integrator specializing in cleanroom infrastructure, HVAC systems, and engineering consultancy, has announced its Audited Financial Results for H2 and FY25.
H2 & FY25 Key Financial Highlights
FY25
- Total Income of ₹ 131.42 Cr, YoY growth of 22.29%
- EBITDA of ₹ 18.97 Cr, YoY growth of 31.52%
- EBITDA Margin (%) of 14.44%, YoY growth of 101 BPS
- PAT of ₹ 11.04 Cr, YoY growth of 29.69%
- PAT Margin (%) of 8.40%, YoY growth of 48…